使用Player FM应用程序离线!
COVID-19 Antiviral Agents and COVID-19 Rebound
Manage episode 347788386 series 2884624
In this episode, Jason Gallagher, PharmD, and Emily Heil, PharmD, MS, BCIDP discuss landmark clinical trials of COVID-19 antivirals for nonhospitalized patients and COVID-19 rebound phenomenon, including:
- EPIC-HR study of nirmatrelvir plus ritonavir
- PINETREE study of remdesivir
- MOVe-OUT and Panoramic studies of molnupiravir
- COVID-19 rebound in treated and untreated patients
Presenters:
Jason Gallagher, PharmD
Clinical Professor
School of Pharmacy
Temple University
Clinical Pharmacy Specialist
Infectious Diseases
Temple University Hospital
Philadelphia, Pennsylvania
Emily Heil, PharmD, MS, BCIDP, AAHIVP
Associate Professor
Department of Pharmacy Practice and Science
University of Maryland School of Pharmacy
Infectious Diseases Clinical Pharmacy Specialist
University of Maryland Medical Center
Baltimore, Maryland
375集单集
Manage episode 347788386 series 2884624
In this episode, Jason Gallagher, PharmD, and Emily Heil, PharmD, MS, BCIDP discuss landmark clinical trials of COVID-19 antivirals for nonhospitalized patients and COVID-19 rebound phenomenon, including:
- EPIC-HR study of nirmatrelvir plus ritonavir
- PINETREE study of remdesivir
- MOVe-OUT and Panoramic studies of molnupiravir
- COVID-19 rebound in treated and untreated patients
Presenters:
Jason Gallagher, PharmD
Clinical Professor
School of Pharmacy
Temple University
Clinical Pharmacy Specialist
Infectious Diseases
Temple University Hospital
Philadelphia, Pennsylvania
Emily Heil, PharmD, MS, BCIDP, AAHIVP
Associate Professor
Department of Pharmacy Practice and Science
University of Maryland School of Pharmacy
Infectious Diseases Clinical Pharmacy Specialist
University of Maryland Medical Center
Baltimore, Maryland
375集单集
所有剧集
×欢迎使用Player FM
Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。